Potent, New Analgesics, Tailor‐Made for Different Purposes

There is a variety of conditions linked to intense pain and stress. Some may last for a relatively short period of time, such as certain surgical interventions; others may have a very extended duration. All of these conditions share a common need for potent analgesics that provide sufficient pain relief and alleviation of the stress response. Extensive research in the lield of narcotic analgesics for more than 25 years has led to the development of a series of potent analgesics tailor-made for difrerent purposes.

[1]  L. Deen,et al.  A comparison of alfentanil and fentanyl in short operations with special reference to their duration of action and postoperative respiratory depression. , 1981, Der Anaesthesist.

[2]  L. Deen,et al.  Alfentanil, a new, potent and very short-acting morphinomimetic for minor operative procedures. A pilot study. , 1981, Der Anaesthesist.

[3]  D. Philbin,et al.  Fentanyl-oxygen anaesthesia for coronary artery surgery: cardiovascular and antidiuretic hormone responses. , 1981, Canadian Anaesthetists' Society journal.

[4]  B. Kay,et al.  Alfentanyl (R39209): initial clinical experience with a new narcotic analgesic , 1980, Anaesthesia.

[5]  B. Kay,et al.  Respiratory effects of a new opiate analgesic, R 39209, in the rabbit: comparison with fentanyl. , 1980, British journal of anaesthesia.

[6]  J. Spierdijk,et al.  ALFENTANYLA NEW NARCOTIC ANESTHETIC INDUCTION AGENT , 1980 .

[7]  T. Stanley,et al.  COMPARISON OF SULFENTANYL — O2AND FENTANYL — O2ANESTHESIA FOR CORONARY ARTERY SURGERY , 1980 .

[8]  T. Stanley,et al.  High Dose Fentanyl Anesthesia for Coronary Artery Surgery: Plasma Fentanyl Concentrations and Influence of Nitrous Oxide on Cardiovascular Responses , 1979, Anesthesia and analgesia.

[9]  T. Stanley,et al.  Cardiovascular responses to clamping of the aorta during epidural and general anesthesia. , 1979 .

[10]  D. Philbin,et al.  Fentanyl-oxygen anaesthesia for coronary artery surgery: cardiovascular and antidiuretic hormone responses , 1979 .

[11]  V. D. Vos.  Immobilisation of free-ranging wild animals using a new drug. , 1978 .

[12]  T. H. Stanley,et al.  Anesthetic requirements and cardiovascular effects of fentanyl-oxygen and fentanyl-diazepam-oxygen anesthesia in man. , 1978 .

[13]  T. Stanley,et al.  The cardiovascular effects of low concentrations of nitrous oxide during morphine anesthesia. , 1974, Anesthesiology.

[14]  W. Stanford,et al.  The Effects of High–dose Morphine on Fluid and Blood Requirements in Open–heart Operations , 1973, Anesthesiology.

[15]  C. Niemegeers,et al.  Bezitramide (R 4845), a new potent and orally long-acting analgesic compound. , 1971, Arzneimittel-Forschung.

[16]  Denson Js,et al.  Fentanyl in anesthesia: a report of 500 cases. , 1970 .

[17]  Janssen Pa,et al.  The inhibitory effect of fentanyl and other morphine-like analgesics on the warm water induced tail withdrawl reflex in rats. , 1963 .

[18]  W. Neff,et al.  Nitrous oxide and oxygen anesthesia with curare relaxation. , 1947, California medicine.

[19]  C. Niemegeers,et al.  Alfentanil (R 39 209) — a particularly short‐acting intravenous narcotic analgesic in rats , 1981 .

[20]  C. Niemegeers,et al.  Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs. , 1976, Arzneimittel-Forschung.

[21]  E. Freye.  Effect of high doses of Fentanyl on myocardial infarction and cardiogenic shock in the dog. , 1974, Resuscitation.